3 Things to Watch on the TSX Index on Thursday

The U.S. stock futures were extremely volatile Thursday before the markets opened. However, China’s comments about working with the U.S. on trade could deliver gains rebounding from a disastrous Wednesday.  

Simple life style relaxation with Asian working business woman healthy lifestyle take it easy resting in comfort hotel or home living room having free time with peace of mind and self health balance

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The U.S. stock futures were extremely volatile Thursday before the markets opened. 

However, China’s comments about working with the U.S. on trade could deliver gains Thursday, rebounding nicely from a disastrous Wednesday.  

Here’s what to watch on the TSX on Thursday. 

Canopy Growth delivers anything but…

Canopy Growth (TSX:WEED)(NYSE:CGC) stock dropped by 14% in pre-market trading Thursday after Canada’s largest cannabis company delivered a stinker of an earnings report Wednesday. Analysts were anything but complimentary about its slowing growth. 

The company was expected to generate $107.1 million in revenue in Q1 2020. It was only able to produce $90.5 million in sales in the quarter. On the bottom line, analysts expected it to lose $0.70 in the quarter; it actually lost $1.28 a share, 83% worse than the consensus. 

There were two positives from the quarter. 

First, revenues were up 249% from the $25.9 million last year. Second, Canopy harvested more than 40,000 kilograms of cannabis in the second quarter, a company record, 183% higher than in the fourth quarter. 

It will be interesting to see how Canopy’s stock trades on Thursday now that investors have had a chance to digest the numbers. 

Bombardier looks attractive

Bombardier (TSX:BBD.B) traded four cents lower on Wednesday, closing the day’s trading at $1.71, just 12 cents off its 52-week low. 

Citi analyst Stephen Trent characterized Bombardier’s stock as “fairly battered” but believes its long-term prognosis is good. 

“Is Bombardier done with asset sales? Only management could answer that question with certainty.

That said, Bombardier now seems well focused on its business jet and transport segments,” Trent wrote in a note to clients Wednesday. “Our forecast does not assume any asset sales, beyond what has already been announced, such as the Q400 and CRJ commercial aircraft programs.”

Trent’s target price for Bombardier is $2,75, below the average analyst price of $3.36, but still providing 61% upside based on current prices. 

Canada Goose looks ready to fly 

Talk about stocks that have taken it on the chin in 2019. 

Canada Goose (TSX:GOOS)(NYSE:GOOS) reported Q1 2020 results Wednesday. Investors weren’t happy with its results or outlook sending its stock down by more than 7.5%. 

However, if investors take a closer look at Canada Goose’s results, D.A. Davidson analyst John Morris believes the company is one of the best names out there, doing everything it can to continue growing. 

“We continue to view GOOS as well-positioned given the company’s growth initiatives, global expansion opportunities, and continued investments in IT and infrastructure to support flexibility and scalability opportunities,” Morris said in a note to clients. 

The analyst has a “buy” rating on Canada Goose with a US$48 target price.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Will Ashworth has no position in any stocks mentioned.  

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »